clock menu more-arrow no yes

Filed under:

Google is building a robotic surgery platform with Johnson & Johnson

New, 10 comments
Spencer Platt/Getty Images

Google is partnering with medical and pharmaceutical company Johnson & Johnson on a robotic surgery project. Johnson & Johnson announced today that Google and its surgery-focused subsidiary Ethicon would share expertise and intellectual property with the goal of creating a "robotic-assisted surgical platform" and developing "new robotic tools and capabilities."

There aren't any specifics on what that might include, nor does it say what specifically each company might be bringing to the table. Robotic surgery can refer to machines that act autonomously, but it frequently means tools that surgeons can "pilot" from a computer screen. It can also significantly add to the cost of surgery, and one of the most popular surgical robots has been accused of underreporting accidents to the FDA, which launched an investigation in 2013. But ideally, it can provide fine-grained controls in hard-to-reach areas, especially as technology advances. Here, Johnson & Johnson describes it as "a type of minimally invasive surgery that uses technology to give surgeons greater control, access and accuracy during the surgical procedure while benefitting patients by minimizing trauma and scarring."

This partnership is a new development for Google, but the company has previously shown interest in medical initiatives. Besides launching its Google Fit health data service last year, it partnered with the pharmaceutical company AbbVie to help develop new drugs for cancer and other age-related diseases — all part of its ultimate moonshot goal of "curing death." Its wearable platform and web services give it access to huge amounts of health data; competitor Apple recently started using similar resources for medical testing. In the more specifically surgery-oriented field, its (mostly unsuccessful) Google Glass headset has been used as a heads-up display for surgeons. Its collaboration with Johnson & Johnson is expected to be finalized over the next few months.